Colgate-Palmolive (NYSE:CL) Sets New 1-Year Low - Should You Sell?

Key Points

• Colgate-Palmolive's stock price recently hit a new 52-week low of $79.93, down from a previous close of $81.17, indicating potential concerns among investors.
• Various analysts have adjusted their price targets for Colgate-Palmolive, with recommendations ranging from an underweight rating to multiple buy ratings, suggesting mixed sentiment in the market.
• The company announced a quarterly dividend of $0.52 per share, providing an annualized yield of 2.6%, which may attract income-focused investors.

Colgate-Palmolive Company (NYSE:CL - Get Free Report)'s share price hit a new 52-week low on Monday . The company traded as low as $80.01 and last traded at $79.93, with a volume of 639633 shares traded. The stock had previously closed at $81.17.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. JPMorgan Chase & Co. decreased their price target on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a report on Monday, August 4th. Citigroup decreased their price target on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a report on Monday, August 4th. UBS Group decreased their price target on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a report on Thursday, July 17th. Barclays increased their price target on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 15th. Finally, Wells Fargo & Company reduced their target price on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a research note on Monday, August 4th. Seven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive has an average rating of "Moderate Buy" and an average target price of $98.00.

Colgate-Palmolive Price Performance

The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The company has a market cap of $63.80 billion, a P/E ratio of 22.18, a PEG ratio of 4.22 and a beta of 0.35. The business's fifty day moving average is $84.78 and its 200 day moving average is $89.05.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. The business had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. Colgate-Palmolive's revenue was up 1.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 EPS. As a group, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.6%. Colgate-Palmolive's payout ratio is currently 58.43%.

Hedge Funds Weigh In On Colgate-Palmolive

Hedge funds and other institutional investors have recently modified their holdings of the company. Westend Capital Management LLC raised its stake in shares of Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock valued at $25,000 after acquiring an additional 140 shares during the last quarter. Westside Investment Management Inc. raised its stake in Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company's stock worth $26,000 after buying an additional 130 shares in the last quarter. Cornerstone Planning Group LLC raised its stake in Colgate-Palmolive by 1,913.3% in the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock worth $28,000 after buying an additional 287 shares in the last quarter. Saudi Central Bank bought a new position in Colgate-Palmolive in the first quarter worth about $29,000. Finally, Vermillion & White Wealth Management Group LLC raised its stake in Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company's stock worth $30,000 after buying an additional 155 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.